Drug intelligence / Profile preview

ammonium lactate + halobetasol

Development stage
Approved
Lead developer
Bristol Myers Squibb
Modality
Small Molecules
Administration
Topical
01

Overview

**Ammonium lactate + halobetasol** is a topical combination drug consisting of ammonium lactate lotion 12% and halobetasol propionate ointment 0.05%, used for corticosteroid-responsive dermatoses such as plaque psoriasis, eczema, rash, and allergic skin reactions. Halobetasol propionate is a superpotent topical corticosteroid small molecule that exerts anti-inflammatory, antipruritic, and vasoconstrictive effects primarily through agonism of the glucocorticoid receptor, leading to suppression of inflammatory mediator signaling. Ammonium lactate acts mainly as a humectant and keratolytic moisturizer that improves skin hydration and scaling. The combination has been used as a topical kit and has been reported in clinical use and publications to improve plaque psoriasis clearance and support maintenance therapy while potentially reducing steroid-associated cutaneous atrophy compared with prolonged corticosteroid use alone.

Brand names
Ultravate + Lac-HydrinUltravate X
Other names
ammonium lactate + halobetasolammonium lactate lotion + halobetasol propionate ointmentammonium lactate 12% + halobetasol propionate 0.05%
02

Targets

MR (Mineralocorticoid receptor)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on ammonium lactate + halobetasol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ammonium lactate + halobetasol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call